U.S. Markets open in 35 mins

CLS Holdings USA, Inc. (CLSH)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0645-0.0045 (-6.52%)
At close: 3:22PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0690
Open0.0575
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0575 - 0.0690
52 Week Range0.0400 - 0.2999
Volume20,390
Avg. Volume142,961
Market Cap8.161M
Beta (5Y Monthly)0.48
PE Ratio (TTM)N/A
EPS (TTM)-0.0600
Earnings DateOct 15, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.07
  • ACCESSWIRE

    CLS Holdings Announces April, May and June Financial Results, Is on Track to Deliver Strong Monthly Revenue During Ongoing Pandemic

    LAS VEGAS, NV / ACCESSWIRE / July 14, 2020 / CLS Holdings USA, Inc. (CLSH) (CLSH), the ''Company'' or ''CLS'', a diversified cannabis company operating as Cannabis Life Sciences, today announced its financial and operational results for the months of May and June 2020 with net revenues of $1,011,907 USD and $1,102,498 USD, respectively. Despite ongoing operational restrictions from COVID-19, the Company has increased its June 2020 net revenue by over 5% compared to June 2019.

  • ACCESSWIRE

    CLS Holdings Announces March Financial Results and Momentous Sales Performance Amidst COVID-19 Business Restrictions

    Oasis has streamlined operations by developing a driver delivery model that is maximizing retail efficiency. Oasis is receiving an average of 350 orders per day and has seen average order size of approximately $80, an increase of 2 times our average in-store order in February of 2020.

  • ACCESSWIRE

    CLS Holdings Provides Shareholder Update

    CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency.